Navigation Links


Compellis in Medical News

Compellis Pharmaceuticals Gets Patent for Obesity-Fighting Nasal Spray CP404

... An U.S based Drug manufacturer, compellis Pharmaceuticals, has been granted the PATENT for C... function to treat obesity and related disorders." compellis Pharmaceuticals is a biopharmaceutical company foc...is Adams, president and chief executive officer of compellis Pharmaceuticals says that the PATENT for CP404 mar...
Compellis in other areas

Compellis Pharmaceuticals

Compellis: Innovative Medicines for Better Living: Obesity, Diabetes, High Blood ... Compellis Pharmaceuticals Awarded Patent for its Therapeutic Platform for ...

FOR IMMEDIATE RELEASE

Compellis Pharmaceuticals has developed an obesity therapy that is based on ... In the study, the Compellis drug was introduced into the nasal passageways of ...

Compellis Pharmaceuticals, Inc. Awarded Second Broad Patent From the ...

Compellis Pharmaceuticals, Inc. Awarded Second Broad Patent From the U.S. Patent Office for Novel Obesity Therapy. - BOSTON, MA--(MARKET WIRE)--Oct 27, 2008 ...

Compellis Pharmaceuticals, Inc. Awarded Second Broad Patent From the ...

BOSTON, MA, Oct 27 (MARKET WIRE) -- Compellis Pharmaceuticals, an early-stage biopharmaceutical company developing novel mechanism-based therapeutics for the ...

AGIPNEWS3719 Compellis Pharmaceuticals Awarded Patent for its ...

Intellectual Property News Agency (ag-IP-news Agency) is a pioneering project established exclusively to cover intellectual property news, announcements, events and ...

Compellis Pharmaceuticals | OneMedPlace | Biopharmaceutical company

A Global resource for Healthcare and life science investors and executives. ... If you work for Compellis Pharmaceuticals and want to update this profile, click ...
Other TagsBiomarkersBiomarkersGraspingRocheRocheRocheAggressiveAggressiveGlobalGlobalGlobalCerebralShiftShiftShiftDifferentDifferentDifferentDifferentDifferent
Breaking Biology News(10 mins):New inherited eye disease discovered 2Introns: A mystery renewed 2Introns: A mystery renewed 3Introns: A mystery renewed 4Experts: Disease-resistant plants enhance profits, client satisfaction 2Olympus Managed Health Care Nominated for Prestigious International Award 57106 1Olympus Managed Health Care Nominated for Prestigious International Award 57106 2American Scientific Resources Acquires Intellectual Property to Worlds Only FDA Approved Home Needle Destruction Device 57103 1American Scientific Resources Acquires Intellectual Property to Worlds Only FDA Approved Home Needle Destruction Device 57103 2American Scientific Resources Acquires Intellectual Property to Worlds Only FDA Approved Home Needle Destruction Device 57103 3Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 1Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 2Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 3Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 4Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 5
Other Contentsdiploiddiploiddiplotenedirectionaldirectionaldirectionaldirectionaldisaccharidesdirectdirectdirectdirectdirectdirectdirectdirectdirectdirectdistaldistaldistaldistaldistaldispersaldispersaldispersal